Breast fat cells kill tumour cells via iron-driven death

Breast tissue contains many fat cells (adipocytes). It was long assumed that they promote tumour growth rather than restrict it, because fat tissue can supply inflammatory substances and growth factors. But this study reveals a different side.

Oxylipins as tumour suppressors

Lean, well-functioning fat cells produce compounds called oxylipins: fatty acid derivatives with a signalling function. The study shows that these oxylipins can push breast cancer cells into ferroptosis, a form of programmed cell death in which iron plays a central role. Ferroptosis differs from other forms of cell death: cells die because fats in their membranes oxidise, causing the cell wall to collapse.

The effect was observed in laboratory models. Whether this also operates in clinical practice, and in which patients, remains unknown.

Why the condition of fat tissue matters

The researchers found this protective effect specifically in lean adipocytes. In dysfunctional fat cells, for example in the context of obesity or chronic inflammation, this inhibitory signal was absent or weakened. That aligns with earlier epidemiological research suggesting that excess body weight increases the risk of certain breast cancers.

From a longevity perspective, this is relevant because the metabolic health of fat tissue is directly linked here to the body’s ability to eliminate tumour cells. Whether this inhibitory capacity declines with age, as fat tissue itself ages, is a question requiring further research.

These findings are preliminary and based on cell and animal models. Clinical translation requires further validation.

Read the original article

Search terms to explore further: ferroptosis tumour resistance adipose tissue | oxylipin adipocyte anti-tumour signalling | ferroptosis breast cancer cell death mechanism